Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · TELA Bio, Inc. (TELA)

TELA Bio regains Nasdaq minimum bid price compliance, matter closed

Neutral Impact 2 of 5 legal/regulatory Written later

TELA Bio, Inc. received a letter from The Nasdaq Stock Market on October 5, 2026, stating that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Market, and the matter is now closed. The company's common stock continues to trade on the Nasdaq Global Market under the symbol TELA, so shareholders face no change in listing status.

Key points

  • Nasdaq letter received October 5, 2026 confirms compliance with the minimum bid price requirement under Listing Rule 5450(a)(1)
  • Nasdaq matter is closed
  • Common stock continues to trade on the Nasdaq Global Market under the symbol TELA

The filing

CompanyTELA Bio, Inc. (TELA)
Form8-K, current report
Filed with the SECOct 6, 2026, 4:05 PM ET
Accession number0001104659-26-114042

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.